CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations
Cell therapy is one of the newest therapeutic approaches for treating tissue destruction diseases and replacing damaged parts in defective tissues. Among different cells, mesenchymal stem cells (MSCs) have received a lot of attention due to their advantages and desirable properties. Also, MSCs-deriv...
Main Authors: | Ali Hazrati, Kosar Malekpour, Sara Soudi, Seyed Mahmoud Hashemi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332222013324 |
Similar Items
-
The CRISPR/Cas9 System Delivered by Extracellular Vesicles
by: Xinglong Zhu, et al.
Published: (2023-03-01) -
CRISPR/Cas9: Principle, Applications, and Delivery through Extracellular Vesicles
by: Katarzyna Horodecka, et al.
Published: (2021-06-01) -
CRISPR/Cas9 and AAV mediated insertion of β2 microglobulin-HLA-G fusion gene protects mesenchymal stromal cells from allogeneic rejection and potentiates the use for off-the-shelf cell therapy
by: Sohsuke Meshitsuka, et al.
Published: (2022-12-01) -
Human mesenchymal stromal cells release functional mitochondria in extracellular vesicles
by: Matthew A. Thomas, et al.
Published: (2022-08-01) -
Cholesterol-linoleic acid liposomes induced extracellular vesicles secretion from immortalized adipose-derived mesenchymal stem cells for in vitro cell migration
by: Jzit Weii Chen, et al.
Published: (2023-12-01)